LEXARIA BIOSCIENCE CORP (LEXX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$4.17+2.46%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · LEXX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 673.5% |
| Our one-year growth estimate | diamond | 95.8% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 577.6 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
LEXX — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-09-09
Unregistered Sales of Equity Securities. The description of the New Warrants, the Placement Agent Warrants and the shares of common stock issuable upon exercise of the New Warrants or the Placement Agent Warrants under
Why it matters: The reverse split aimed to restore Nasdaq compliance. A formal notice can confirm the listing risk has eased.
Supportive ifNasdaq confirms LEXX meets the $1.00 minimum bid-price rule and closes the listing matter.
Worry ifNasdaq decides to delist LEXX or says it still fails the $1.00 minimum bid-price rule.
Why it matters: The company reported ongoing losses and no revenue growth in the inputs. New study results or partner news could show progress beyond spending.
Watch forThe November 25 report names a new study result or partner step for DehydraTECH. It gives a clear date or measured result.
Also watch forThe report gives no new study result or partner step, or says planned research was delayed or canceled.
Why it matters: The cash deal also gives investors new warrants for up to 907,938 shares. Exercise could add shares and more cash.
Worry ifA filing shows that holders exercise the new Series A or Series B warrants for common shares.
Less concerning ifThe warrants expire without exercise, and filings show no new shares issued from them.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$539 on $10,000 · ±5.4% | How much price usually moves either way. |
| Bad day | $1,164 loss on $10,000 · 11.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,706 loss on $10,000 · 87.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.